Treatment planning with implantable bronchial isolation devices
Disclosed is a treatment planning method that can be used to maximize the effectiveness of minimally invasive treatment on a patient. Pursuant to the treatment planning method, the presence of lung disease, such as emphysema, is first identified, followed by a determination of the distribution and extent of damage of the disease, followed by a determination of whether the patient is suitable for treatment, and a determination of the appropriate strategy for treatment for a suitable patient.
1 . A method of determining a treatment strategy for minimally invasive lung treatment, comprising:
performing at least one diagnostic procedure on a patient to obtain at least one diagnostic result; and
determining that the patient is eligible for minimally invasive lung treatment if at least one diagnostic result satisfies predetermined eligibility criteria.
2 . The method of claim 1 , wherein the at least one diagnostic procedure comprises a spirometric test and wherein the at least one diagnostic result includes at least one of the group consisting of forced expiratory volume in one second (FEV 1 ), forced vital capacity (FVC), and forced expiratory flow, 25% to 75% (FEF 25%-75% ).
3 . The method of claim 1 , wherein the at least one diagnostic procedure comprises a spirometric test and wherein the at least one diagnostic result includes a combination of two or more of the group consisting of forced expiratory volume in one second (FEV 1 ), forced vital capacity (FVC), and forced expiratory flow, 25% to 75% (FEF 25%-75% ).
4 . The method of claim 2 , wherein the eligibility criteria comprises FVC and wherein the patient is eligible for minimally invasive lung treatment if the patient's FVC is less than 80 percent of FVC predicted.
5 . The method of claim 2 , wherein the eligibility criteria comprises FVC and wherein the patient is eligible for minimally invasive lung treatment if the patient's FVC is less than 70 percent of FVC predicted.
6 . The method of claim 2 , wherein the eligibility criteria comprises FVC and wherein the patient is eligible for minimally invasive lung treatment if the patient's FVC is less than 60 percent of FVC predicted.
7 . The method of claim 2 , wherein the eligibility criteria comprises FVC and wherein the patient is eligible if the patient's FVC is less than 50 percent of FVC predicted.
8 . The method of claim 2 , wherein the eligibility criteria comprises FVC and wherein the patient is eligible if the patient's FVC is less than 40 percent of FVC predicted.
9 . The method of claim 2 , wherein the diagnostic procedure comprises at least one plethysmographic test.
10 . The method of claim 1 , wherein the diagnostic procedure comprises an imaging procedure.
11 . The method of 10 , wherein the imaging procedure comprises a computed tomography (CT) scan.
12 . The method of claim 1 , wherein the at least one diagnostic procedure yields multiple diagnostic results, and wherein the patient is eligible if a combination of the diagnostic results meet eligibility criteria.
13 . The method of claim 1 , further comprising identifying at least one lung region to be targeted for minimally-invasive lung treatment based on the diagnostic results.
14 . The method of claim 1 , further comprising performing a second diagnostic procedure to obtain second diagnostic results and identifying at least one lung region to be targeted for minimally-invasive lung treatment based on the second diagnostic results.
15 . The method of claim 1 , wherein the diagnostic procedure provides diagnostic results that indicate aggregate information regarding the lung function of both lungs.
16 . The method of claim 1 , wherein the diagnostic procedure provides diagnostic results that provide regional or localized information about the disease state of the patient's lungs.
17 . A method as defined in claim 1 , further comprising developing a treatment strategy and wherein the treatment strategy is to completely isolate a lung lobe using minimally invasive bronchial isolation device.
18 . A method as defined in claim 1 , further comprising developing a treatment strategy and wherein the treatment strategy is to intentionally refrain from placing a minimally invasive bronchial isolation device in at least one bronchial airway leading to the target lobe, while placing at least one minimally invasive bronchial isolation device in a bronchial airway leading to that target lobe.
19 . A method of determining a treatment strategy for minimally invasive lung treatment of a patient, comprising:
performing at least one test on the patient to obtain data indicative of a lung disease;
developing a treatment plan based on the data, wherein the treatment plan specifically identifies at least one lung region to be targeted for minimally-invasive lung treatment.
20 . A method as defined in claim 19 , wherein the data provides information relating to localized lung characteristics.
21 . A method as defined in claim 19 , wherein the data provides information relating to global lung characteristics.
22 . A method as defined in claim 19 , wherein the at least one test comprises a computed tomography (CT) scan or a high-resolution computed tomography (HRCT) scan and wherein the data comprises at least one cross-sectional image of the patient's lung.
23 . A method as defined in claim 19 , wherein the at least one test is performed repeatedly during the time it takes for the patient to perform a breathing maneuver.
24 . A method as defined in claim 19 , further comprising analyzing the data to obtain at least one score indicative of the level of disease in at least one region of the patient's lung.
25 . A method as defined in claim 24 , wherein the at least one region comprises a lobe of the lung.
26 . A method as defined in claim 24 , wherein the score is obtained by a computer.
27 . A method as defined in claim 24 , wherein the treatment plan is developed based on a comparison of the scores obtained for the lung regions.
28 . A method as defined in claim 19 , wherein the minimally invasive treatment includes placing one or more bronchial isolation devices in the lung to completely isolate a targeted lung region.
29 . A method as defined in claim 19 , wherein a plurality of bronchial passageways provide air to the targeted lung region, and wherein the treatment plan selectively identifies at least one of the bronchial passageways for placement of a bronchial isolation device.
30 . A method as defined in claim 19 , wherein the treatment plan intentionally refrains from placing a bronchial isolation device in at least one of the bronchial passageways leading to the targeted lung region.
31 . A method of planning lung treatment, comprising:
detecting the presence, degree, and distribution of a disease in the lung;
analyzing results of the detecting step to obtain at least one grade indicative of the level of disease in at least one region of the lung; and
identifying a lung or a region of the lung to be treated based on at least one grade obtained in the analyzing step.
32 . A method as defined in claim 31 , additionally comprising determining whether a patient is suitable for treatment based on the grades obtained in the analyzing step.
33 . A method as defined in claim 31 , wherein detecting the presence, degree, and distribution of a disease in the lung comprises determining a region of the lung that is diseased.
34 . A method as defined in claim 31 , wherein a computed tomography (CT) scan is used to detect the presence, degree, and distribution of the disease in the lung.
35 . A method as defined in claim 31 , wherein a high-resolution computed tomography (HRCT) scan is used to detect the presence, degree, and distribution of the disease in the lung.
36 . A method as defined in claim 31 , wherein the at least one grade obtained in the analyzing step includes emphysema score, heterogeneity score, and destruction score.